A

Alterity Therapeutics
ATH

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
A$100.40M
EV
A$95.97M
Shares Outstanding
10.37B
Beta
0.71

Wall Street View

Analyst Rating
NO_OPINION
Analyst Target Price
A$0.08
P/E 2025E
-
P/Revenue 2025E
30.96x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Alterity Therapeutics Limited

gainify

A

Alterity Therapeutics Limited

ATH

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer’s disease, Huntington disease, Parkinson’s disease, and other neurological disorders in Australia. The company’s lead drug candidate is ATH434, a small molecu...

Sector

Healthcare

Industry

Biotechnology

CEO

Stamler, David

Employees

10

IPO Date

2000-03-28

Headquarters

350 Collins Street, Suite 4, Level 14, Melbourne, Victoria, 3000, Australia

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.